South Africa is in the process of finalising a R25 million investment to boost pan-African Covid-19 vaccine manufacturing capabilities.
“We are currently in the process of finalising a R25 million investment to boost pan-African vaccine manufacturing capabilities through the African Renaissance Fund.” “As the international community, we have been unanimous that services, supplies, products and technologies for prevention, treatment and care of COVID-19 must be available to all. No country must be left behind.”
“One looks for instance at the advances in ventilator development and production in developing countries.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação: